# Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

> **NCT00748527** · PHASE2 · TERMINATED · sponsor: **Cancer Research UK** · enrollment: 134 (estimated)

## Conditions studied

- Fallopian Tube Cancer
- Ovarian Cancer
- Peritoneal Cavity Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** decitabine

## Key facts

- **NCT ID:** NCT00748527
- **Lead sponsor:** Cancer Research UK
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-07
- **Primary completion:** 2009-12
- **Final completion:** 2010-11
- **Target enrollment:** 134 (ESTIMATED)
- **Why stopped:** The study was "withdrawn" due to certain adverse events \[hypersensitivity\].
- **Last updated:** 2013-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00748527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00748527, "Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00748527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*